Библиография

1. 1. Величковский Б.М., Боринская С.А., Вартанов А.В. и др. Нейрокогнитивные особенности носителей аллеля ε4 гена аполипопротеина Е (APOE) // теоретическая и экспериментальная психология. 2009. т. 2. № 4. С. 25–37.
2. 2. Мошетова Л.К., Абрамова О.И., Туркина К.И. и др. От клеточного старения до возрастной макулярной дегенерации: роль теломер // рМЖ. Клиническая офтальмология. 2020. т. 20. № 3. С. 148–151. https://doi.org/10.32364/2311-7729-2020-20-3-148-151
3. 3. Павлов К.И., Мухин В.Н., Клименко В.М., Анисимов В.Н. Система теломера-теломераза и психические процессы при старении, в норме и патологии (обзор литературы) // Успехи геронтологии. 2017. т. 30. № 1. С. 17–26.
4. 4. Разумникова О.М. Закономерности старения мозга и способы активации его компенсаторных ресурсов // Успехи физиол. наук. 2015. т. 46. № 2. С. 3–16.
5. 5. Третьякова В.Д. Возрастные изменения в мозге и факторы влияющие на них // Бюллетень науки и практики. 2022. V. 8. № https://doi.org/10.33619/2414-2948/80/20
6. 6. Третьякова В.Д., Пульцина К.И. Старение мозга: ключевые теории и нейрофизиологические инсайты // Клиническая и специальная психология. 2024. т. 13. № 4. С. 5–28. doi: 10.17759/cpse.2024130401
7. 7. Чердак М.А. Механизмы нейрокогнитивной адаптации при старении // Проблемы геронауки. 2023. № 2. С. 94–101. https://doi.org/10.37586/2949-4745-2-2023-94-101
8. 8. Широкова И.В. Исторические аспекты становления понятия «Исполнительные функции». Обзор иностранных источников // Комплексные исследования детства. 2022. т. 4. № 4. С. 333–336. https://orcid.org/0000-0003-1556-5584
9. 9. Amano H., Chaudhury A., Rodriguez-Aguayo C. et al. Telomere dysfunction induces sirtuin repression that drives telomere-dependent disease // Cell metabolism. 2019. V. 29. № 6. P. 1274–1290. e9. https://doi.org/10.1016/j.cmet.2019.03.001
10. 10. Andrews M.G., Subramanian L., Kriegstein A.R. mTOR signaling regulates the morphology and migration of outer radial glia in developing human cortex // Elife. 2020. V. 9. P. e58737. https://doi.org/10.7554/eLife.58737
11. 11. Anthony M., Lin F. A systematic review for functional neuroimaging studies of cognitive reserve across the cognitive aging spectrum // Archives of Clinical Neuropsychology. 2018. V. 33. № 8. P. 937–948. https://doi.org/10.1093/arclin/acx125
12. 12. Arce Rentería M., Vonk J.M., Felix G. et al. Illiteracy, dementia risk, and cognitive trajectories among older adults with low education // Neurology. 2019. V. 93. № 24. P. e2247–e2256. https://doi.org/10.1212/WNL.0000000000008587
13. 13. Baker D., Childs B., Durik M. et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan // Nature. 2016. V. 530. № 7589. P. 184–189. https://doi.org/10.1038/nature16932
14. 14. Baker D., Wijshake T., Tchkonia T. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders // Nature. 2011. V. 479. № 7372. P. 232–236. https://doi.org/10.1038/nature10600
15. 15. Bektas A., Schurman S.H., Sen R., Ferrucci L. Aging, inflammation and the environment // Experimental gerontology. 2018. V. 105. P. 10–18. https://doi.org/10.1016/j.exger.2017.12.015
16. 16. Berchtold N.C., Coleman P.D., Cribbs D.H. et al. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease // Neurobiology of aging. 2013. V. 34. № 6. P. 1653–1661. https://doi.org/10.1016/j.neurobiolaging.2012.11.024
17. 17. Birch J., Gil J. Senescence and the SASP: Many therapeutic avenues // Genes & development. 2020. V. 34. № 23–24. P. 1565–1576. https://doi.org/10.1101/gad.343129.120
18. 18. Budni J., Bellettini-Santos T., Mina F. et al. The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease // Aging and disease. 2015. V. 6. № 5. P. 331. https://doi.org/10.14336/AD.2015.0825
19. 19. Cabeza R., Albert M., Belleville S. et al. Cognitive neuroscience of healthy aging: Maintenance, reserve, and compensation // Nature Reviews. Neuroscience. 2018. V. 19. № 11. P. 701. https://doi.org/10.1038/s41583-018-0068-2
20. 20. Campbell K.L., Lustig C., Hasher L. Aging and inhibition: Introduction to the special issue // Psychology and Aging. 2020. V. 35. № 5. P. 605. https://doi.org/10.1037/pag0000564
21. 21. Castro-Pérez E., Emilio Soto-Soto E., Marizabeth Pérez-Carambot M. et al. Identification and characterization of the V (D) J recombination activating gene 1 in long-term memory of context fear conditioning // Neural Plasticity. 2016. V. 2016. 1752176 https://doi.org/10.1155/2016/1752176
22. 22. Cherbuin N., Kim S., Anstey K.J. Dementia risk estimates associated with measures of depression: A systematic review and meta-analysis // BMJ Open. 2015. V. 5. № 12. P. e008853. https://doi.org/10.1136/bmjopen-2015-008853
23. 23. Cohen-Manheim I., Doniger G.M., Sinnreich R. et al. Increased attrition of leukocyte telomere length in young adults is associated with poorer cognitive function in midlife // European journal of epidemiology. 2016. V. 31. P. 147–157. https://doi.org/10.1007/s10654-015-0051-4
24. 24. Crowe S.L., Movsesyan V.A., Jorgensen T.J., Kondratyev A. Rapid phosphorylation of histone H2A. X following ionotropic glutamate receptor activation // European Journal of Neuroscience. 2006. V. 23. № 9. P. 2351–2361. https://doi.org/10.1111/j.1460-9568.2006.04768.x
25. 25. Daniele S., Giacomelli C., Martini C. Brain ageing and neurodegenerative disease: The role of cellular waste management // Biochemical pharmacology. 2018. V. 158. P. 207–216. https://doi.org/10.1016/j.bcp.2018.10.030
26. 26. de Jager P.L., Srivastava G., Lunnon K. et al. Alzheimer's disease: Early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci // Nature neuroscience. 2014. V. 17. № 9. P. 1156–1163. https://doi.org/10.1038/nn.3786
27. 27. De Lucia C., Murphy T., Steves C.J. et al. Lifestyle mediates the role of nutrient-sensing pathways in cognitive aging: Cellular and epidemiological evidence // Communications Biology. 2020. V. 3. № 1. P. 157. https://doi.org/10.1038/s42003-020-0844-1
28. 28. Emrani S., Arain H.A., DeMarshall C., Nuriel T. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: A systematic review // Alzheimer's research & therapy. 2020. V. 12. № 1. P. 141. https://doi.org/10.1186/s13195-020-00712-4
29. 29. Ferguson H.J., Brunsdon V.E.A., Bradford E.E.F. The developmental trajectories of executive function from adolescence to old age // Scientific reports. 2021. V. 11. № 1. P. 1382. https://doi.org/10.1038/s41598-020-80866-1
30. 30. Fischer M.E., Cruickshanks K.J., Schubert C.R. et al. Age‐related sensory impairments and risk of cognitive impairment // Journal of the American Geriatrics Society. 2016. т. 64. № 10. P. 1981–1987. https://doi.org/10.1111/jgs.14308
31. 31. Gaspar-Silva F., Trigo D., Magalhaes J. Ageing in the brain: Mechanisms and rejuvenating strategies // Cellular and Molecular Life Sciences. 2023. V. 80. № 7. P. 1–21. https://doi.org/10.1007/s00018-023-04832-6
32. 32. Geerligs L., Saliasi E., Maurits N.M. et al. Brain mechanisms underlying the effects of aging on different aspects of selective attention // NeuroImage. 2014. V. 91. P. 52–62. https://doi.org/10.1016/j.neuroimage.2014.01.029
33. 33. Gollihue J.L., Norris C.M. Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury // Ageing research reviews. 2020. V. 59. P. 101039. https://doi.org/10.1016/j.arr.2020.101039
34. 34. Guo J., Huang X., Dou L. et al. Aging and aging-related diseases: From molecular mechanisms to interventions and treatments // Signal Transduction and Targeted Therapy. 2022. V. 7. № 1. P. 391. https://doi.org/10.1038/s41392-022-01251-0
35. 35. Han B., Chen H., Yao Y. et al. Genetic and non-genetic factors associated with the phenotype of exceptional longevity & normal cognition // Scientific Reports. 2020. V. 10. № 1. P. 19140. https://doi.org/10.1038/s41598-020-75446-2
36. 36. Han R., Liang J., Zhou B. Glucose metabolic dysfunction in neurodegenerative diseases — new mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic reprogramming // International Journal of Molecular Sciences. 2021. V. 22. № 11. P. 5887. https://doi.org/10.3390/ijms22115887
37. 37. Hardcastle C., O’Shea A., Kraft J.N. et al. Contributions of hippocampal volume to cognition in healthy older adults // Frontiers in aging neuroscience. 2020. V. 12. P. 593833. https://doi.org/10.3389/fnagi.2020.593833
38. 38. Hartshorne J.K., Germine L.T. When does cognitive functioning peak? The asynchronous rise and fall of different cognitive abilities across the life span // Psychological science. 2015. V. 26. № 4. P. 433–443. https://doi.org/10.1177/0956797614567339
39. 39. Hou Y., Dan X., Babbar M. et al. Ageing as a risk factor for neurodegenerative disease // Nature Reviews Neurology. 2019. V. 15. № 10. P. 565–581. https://doi.org/10.1038/s41582-019-0244-7
40. 40. Jucker M. The benefits and limitations of animal models for translational research in neurodegenerative diseases // Nature medicine. 2010. V. 16. № 11. P. 1210–1214. https://doi.org/10.1038/nm.2224
41. 41. Kalpouzos G., Rizzuto D., Keller L. et al. Telomerase gene (hTERT) and survival: results from two Swedish cohorts of older adults // Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2016. V. 71. № 2. P. 188–195. https://doi.org/10.1093/gerona/glu222
42. 42. Kase Y., Shimazaki T., Okano H. Current understanding of adult neurogenesis in the mammalian brain: How does adult neurogenesis decrease with age? // Inflammation and regeneration. 2020. V. 40. P. 1–6. https://doi.org/10.1186/s41232-020-00122-x
43. 43. Kepchia D., Huang L., Dargusch R. et al. Diverse proteins aggregate in mild cognitive impairment and Alzheimer’s disease brain // Alzheimer's research & therapy. 2020. V. 12. № 1. P. 1–20. https://doi.org/10.1186/s13195-020-00641-2
44. 44. Kirova A.M., Bays R.B., Lagalwar S. Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer’s disease // BioMed research international. 2015. V. 2015. № 1. P. 748212. https://doi.org/10.1155/2015/748212
45. 45. Konopka A., Atkin J.D. The role of DNA damage in neural plasticity in physiology and neurodegeneration // Frontiers in Cellular Neuroscience. 2022. V. 16. P. 836885. https://doi.org/10.3389/fncel.2022.836885
46. 46. Leong R.L.F., Lo J.C., Sim S.K.Y. et al. Longitudinal brain structure and cognitive changes over 8 years in an East Asian cohort // Neuroimage. 2017. V. 147. P. 852–860. https://doi.org/10.1016/j.neuroimage.2016.10.016
47. 47. Li H., Hirano S., Furukawa S. et al. The relationship between the striatal dopaminergic neuronal and cognitive function with aging // Frontiers in aging neuroscience. 2020. V. 12. P. 41. https://doi.org/10.3389/fnagi.2020.00041
48. 48. Liguori I., Russo G., Curcio F. et al. Oxidative stress, aging, and diseases // Clinical interventions in aging. 2018. P. 757–772. https://doi.org/10.2147/CIA.S158513
49. 49. López-Otín C., Blasco M.A., Partridge L., Serrano M. The hallmarks of aging // Cell. 2013. V. 153. № 6. P. 1194–1217. https://doi.org/10.1016/j.cell.2013.05.039
50. 50. Lunnon K., Smith R., Hannon E. et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease // Nature neuroscience. 2014. V. 17. № 9. P. 1164–1170. https://doi.org/10.1038/nn.3782
51. 51. Ma A., Dai X. The relationship between DNA single-stranded damage response and doublestranded damage response // Cell Cycle. 2018. V. 17. № 1. P. 73–79. https://doi.org/10.1080/15384101.2017.1403681
52. 52. Ma S.L., Lau E.S.S., Suen E.W.C. et al. Telomere length and cognitive function in southern Chinese community-dwelling male elders // Age and ageing. 2013. V. 42. № 4. P. 450–455. https://doi.org/10.1093/ageing/aft036
53. 53. Maharani A., Pendleton N., Leroi I. Hearing impairment, loneliness, social isolation, and cognitive function: Longitudinal analysis using English longitudinal study on ageing // The American Journal of Geriatric Psychiatry. 2019. V. 27. № 12. P. 1348–1356. https://doi.org/10.1016/j.jagp.2019.07.010
54. 54. McGrattan A.M., McGuinness B., McKinley M.C. et al. Diet and inflammation in cognitive ageing and Alzheimer’s disease // Current nutrition reports. 2019. V. 8. P. 53–65. https://doi.org/10.1007/s13668-019-0271-4
55. 55. McKinnon P.J. Topoisomerases and the regulation of neural function // Nature Reviews Neuroscience. 2016. V. 17. № 11. P. 673–679. https://doi.org/10.1038/nrn.2016.101
56. 56. Möller C., Hafkemeijer A., Pijnenburg Y.A.L. et al. Different patterns of cortical gray matter loss over time in behavioral variant frontotemporal dementia and Alzheimer's disease // Neurobiology of aging. 2016. V. 38. P. 21–31. https://doi.org/10.1016/j. neurobiolaging.2015.10.020
57. 57. Murman D.L. The impact of age on cognition // Seminars in hearing. Thieme Medical Publishers. 2015. V. 36. № 03. P. 111–121. https://doi.org/10.1055/s-0035-1555115
58. 58. Negredo P.N., Yeo R.W., Brunet A. Aging and rejuvenation of neural stem cells and their niches // Cell stem cell. 2020. V. 27. № 2. P. 202–223. https://doi.org/10.1016/j.stem.2020.07.002
59. 59. Nettiksimmons J., Ayonayon H., Harris T. et al. Development and validation of risk index for cognitive decline using blood-derived markers // Neurology. 2015. V. 84. № 7. P. 696–702. https://doi.org/10.1212/WNL.0000000000001263
60. 60. Oosterhuis E.J., Slade K., May P.J.C. et al. Toward an understanding of healthy cognitive aging: The importance of lifestyle in cognitive reserve and the scaffolding theory of aging and cognition // The Journals of Gerontology: Series B. 2023. V. 78. № 5. P. 777–788. https://doi.org/10.1093/geronb/gbac197
61. 61. Park D.C., Festini S.B. Theories of memory and aging: A look at the past and a glimpse of the future // Journals of Gerontology Series B: Psychological Sciences and Social Sciences. 2017. V. 72. № 1. P. 82–90. https://doi.org/10.1093/geronb/gbw066
62. 62. Pettigrew C., Soldan A. Defining cognitive reserve and implications for cognitive aging // Current neurology and neuroscience reports. 2019. V. 19. P. 1–12. https://doi.org/10.1007/s11910-019-0917-z
63. 63. Pietzuch M., King A.E., Ward D.D., Vickers J.C. The influence of genetic factors and cognitive reserve on structural and functional resting-state brain networks in aging and Alzheimer’s disease // Frontiers in aging neuroscience. 2019. V. 11. P. 30. https://doi.org/10.3389/fnagi.2019.00030
64. 64. Polidori M.C. Embracing complexity of (brain) aging // FEBS letters. 2024. V. 598. № 17. P. 2067–2073. https://doi.org/10.1002/1873-3468.14941
65. 65. Porokhovnik L.N., Veiko N.N., Ershova E.S., Kostyuk S.V. The role of human satellite III (1q12) copy number variation in the adaptive response during aging, stress, and pathology: a pendulum model // Genes. 2021. V. 12. № 10. P. 1524. https://doi.org/10.3390/genes12101524
66. 66. Réus G.Z., Abaleira H.M., Michels M. et al. Anxious phenotypes plus environmental stressors are related to brain DNA damage and changes in NMDA receptor subunits and glutamate uptake // Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2015. V. 772. P. 30–37. https://doi.org/10.1016/j.mrfmmm.2014.12.005
67. 67. Reuter-Lorenz P.A., Park D.C. Cognitive aging and the life course: A new look at the scaffolding theory // Current Opinion in Psychology. 2023. P. 101781. https://doi.org/10.1016/j.copsyc.2023.101781
68. 68. Rossiello F., Jurk D., Passos J.F. et al. Telomere dysfunction in ageing and age-related diseases // Nature cell biology. 2022. V. 24. № 2. P. 135–147. https://doi.org/10.1038/s41556-022-00842-x
69. 69. Ruthruff E., Lien M.C. Aging and attention // Encyclopedia of geropsychology. 2016. P. 1–7. https://doi.org/10.1007/978-981-287-0803_227-1
70. 70. Sakata K., Duke S.M. Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus // Neuroscience. 2014. V. 260. P. 265–275. https://doi.org/10.1016/j. neuroscience.2013.12.013
71. 71. Sakata K., Overacre A.E. Promoter IV‐BDNF deficiency disturbs cholinergic gene expression of CHRNA 5, CHRM 2, and CHRM 5: Effects of drug and environmental treatments // Journal of neurochemistry. 2017. V. 143. № 1. P. 49–64. https://doi.org/10.1111/jnc.14129
72. 72. Salthouse T. A. Selective review of cognitive aging // Journal of the International neuropsychological Society. 2010. V. 16. № 5. P. 754–760. https://doi.org/10.1017/S1355617710000706
73. 73. Salthouse T.A. The processing-speed theory of adult age differences in cognition // Psychological review. 1996. V. 103. № 3. P. 403. https://doi.org/10.1037/0033-295X.103.3.403
74. 74. Sanchez-Mut J.V., Heyn H., Vida E. et al. Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns // Translational psychiatry. 2016. V. 6. № 1. P. e718–e718. https://doi.org/10.1038/tp.2015.214
75. 75. Saxton R.A., Sabatini D.M. mTOR signaling in growth, metabolism, and disease // Cell. 2017. V. 168. № 6. P. 960–976. https://doi.org/10.1016/j.cell.2017.02.004
76. 76. Shay J.W., Wright W.E. Telomeres and telomerase: three decades of progress // Nature Reviews Genetics. 2019. V. 20. № 5. P. 299–309. https://doi.org/10.1038/s41576-019-0099-1
77. 77. Sikora E., Bielak-Zmijewska A., Dudkowska M. et al. Cellular senescence in brain aging // Frontiers in Aging Neuroscience. 2021. V. 13. P. 646924. https://doi.org/10.3389/fnagi.2021.646924
78. 78. Soto-Palma C., Niedernhofer L.J., Faulk C.D., Dong X. Epigenetics, DNA damage, and aging // The Journal of clinical investigation. 2022. V. 132. № 16. https://doi.org/10.1172/JCI158446.
79. 79. Stern Y., Barnes C.A., Grady C. et al. Brain reserve, cognitive reserve, compensation, and maintenance: Operationalization, validity, and mechanisms of cognitive resilience // Neurobiology of aging. 2019. V. 83. P. 124–129. https://doi.org/10.1016/j. neurobiolaging.2019.03.022
80. 80. Stott R.T., Kritsky O., Tsai L.H. Profiling DNA break sites and transcriptional changes in response to contextual fear learning // PLoS One. 2021. V. 16. № 7. P. e0249691. https://doi.org/10.1371/journal.pone.0249691
81. 81. Swerdlow R.H. The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease // International review of neurobiology. 2020. V. 154. P. 207–233. https://doi.org/10.1016/bs.irn.2020.01.008
82. 82. Trigo D., Nadais A., Carvalho A. et al. Mitochondria dysfunction and impaired response to oxidative stress promotes proteostasis disruption in aged human cells // Mitochondrion. 2023. V. 69. P. 1–9. https://doi.org/10.1016/j.mito.2022.10.002
83. 83. Tripp A., Oh H., Guilloux J. P. et al. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder // American Journal of Psychiatry. 2012. V. 169. № 11. P. 1194–1202. https://doi.org/10.1176/appi.ajp.2012.12020248
84. 84. Uyeda A., Onishi K., Hirayama T. et al. Suppression of DNA double-strand break formation by DNA polymerase β in active DNA demethylation is required for development of hippocampal pyramidal neurons // Journal of Neuroscience. 2020. V. 40. № 47. P. 9012–9027. https://doi.org/10.1523/ JNEUROSCI.0319-20.2020
85. 85. Veiko N.N., Ershova E.S., Veiko R.V., Umriukhin P. E. et al. Mild cognitive impairment is associated with low copy number of ribosomal genes in the genomes of elderly people // Frontiers in genetics. 2022. V. 13. P. 967448. https://doi.org/10.3389/fgene.2022.967448
86. 86. Verhaeghen P. Aging and executive control: Reports of a demise greatly exaggerated // Current Directions in Psychological Science. 2011. V. 20. № 3. P. 174–180. https://doi.org/10.1177/0963721411408772
87. 87. Verkhratsky A., Zorec R. Neuroglia in cognitive reserve // Molecular Psychiatry. 2024. P. 1–6. https://doi.org/10.1038/s41380-024-02644-z
88. 88. Wang Y., Du Y., Li J., Qiu C. Lifespan intellectual factors, genetic susceptibility, and cognitive phenotypes in aging: Implications for interventions // Frontiers in Aging Neuroscience. 2019. V. 11. P. 129. https://doi.org/10.3389/fnagi.2019.00129
89. 89. Welch G., Tsai L.H. Mechanisms of DNA damage‐mediated neurotoxicity in neurodegenerative disease // EMBO reports. 2022. V. 23. № 6. P. e54217. https://doi.org/10.15252/embr.202154217
90. 90. Welty S., Teng Y., Liang Z. et al. RAD52 is required for RNA-templated recombination repair in post-mitotic neurons // Journal of Biological Chemistry. 2018. V. 293. № 4. P. 1353–1362. https://doi.org/10.1074/jbc.M117.808402
91. 91. Yu H., Su Y., Shin J. et al. Tet3 regulates synaptic transmission and homeostatic plasticity via DNA oxidation and repair // Nature neuroscience. 2015. V. 18. № 6. P. 836–843. https://doi.org/10.1038/nn.4008
92. 92. Zanto T.P., Gazzaley A. Aging of the frontal lobe // Handbook of clinical neurology. 2019. V. 163. P. 369–389. https://doi.org/10.1016/B978-0-12-804281-6.00020-3
93. 93. Zhang W., Chen Y., Yang X. et al. Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease // PLoS One. 2012. V. 7. № 10. P. e47029 https://doi.org/10.1371/journal.pone.0047029